Search by Drug Name or NDC
NDC 50090-5405-03 Buspirone Hydrochloride 15 mg/1 Details
Buspirone Hydrochloride 15 mg/1
Buspirone Hydrochloride is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by A-S Medication Solutions. The primary component is BUSPIRONE HYDROCHLORIDE.
MedlinePlus Drug Summary
Buspirone is used to treat anxiety disorders or in the short-term treatment of symptoms of anxiety. Buspirone is in a class of medications called anxiolytics. It works by changing the amounts of certain natural substances in the brain.
Related Packages: 50090-5405-03Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Buspirone
Product Information
| NDC | 50090-5405 |
|---|---|
| Product ID | 50090-5405_c479da67-ccd3-4cae-96c2-0d99d4a527ab |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Buspirone Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Buspirone Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 15 |
| Active Ingredient Units | mg/1 |
| Substance Name | BUSPIRONE HYDROCHLORIDE |
| Labeler Name | A-S Medication Solutions |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA202330 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 50090-5405-03 (50090540503)
| NDC Package Code | 50090-5405-3 |
|---|---|
| Billing NDC | 50090540503 |
| Package | 90 TABLET in 1 BOTTLE (50090-5405-3) |
| Marketing Start Date | 2020-12-09 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |